|
Final
Segment #1: |
 |
'Mad
Mail'
Viewers ask, Cramer
answers... |
|
|
|
Tuesday,
May 26, 2009 |
|
|
 |
 |
|
See viewer email
questions below, and
Cramer's answers on
whether or not he
likes the stock in
question, or general
market comments...
Jim:
Before
we get to
Mad Mail we
have a bit
of homework
to catch up
on… last
Friday,
Brock from
California
asked about
CardioNet,
Inc. (BEAT)…
BEAT is a
medical
device
company,
they are the
industry
leader, 80%
share in
mobile
cardiac
outpatient
telemetry
systems…
Imgot is
said to
identify
irregular
activity of
the heart,
like fast,
slow, or
irregular
heartbeats…
much better
than
traditional
heart
monitors…
but it has
been weak
because of
fears of
reimbursement
cuts from
the
government…
back in
April,
Jeffries
initiated on
the stock
with an
under
perform…
that is
right, they
said sell…
saying that
channel
checks
indicated a
reimbursement
rate cut for
Imgot in
2009... last
Tuesday the
company
announced
that its
2009
reimbursement
rate was
unchanged
from what it
was last
year… that
caused a pop
in the
stock… the
stock has
pulled back
a bit as
there is
another
reimbursement
rate
decision
coming up
from CMS as
early as
July… and
Jeffries
expects a
reimbursement
rate cut
there as
well… man, I
have got to
stay away
from this
thing… too
many
reimbursement
cuts.
Also, we
recommended
Cougar
Biotechnology,
Inc. (CGRB)
on
3/13/09...
that is
right March
13th at
$27.27, it
was one of
our spec
plays… it
was a spec
bio-tech
play, these
were the
guys who had
that
Peratrone,
that
prostate
cancer
treatment
that was
going thru
phase 3
trial… hey,
better to be
lucky than
good… on
Friday,
Cougar got a
$43 share
bid from
Johnson & Johnson (JNJ)…
the stock is
trading at
$42.74, that
is a 54%
gain from
spec Friday…
I do not
want you to
be a pig…
bulls make
money, bears
make money,
pigs get
slaughtered…
that is a
huge gain… I
command you
to take it.
|
|
|
|
Continued below...
|
|
|
|
|
|
|
|
|
|
Tuesday,
October 22, 2008
(Cont'd from
above)...
▼ ▼
▼ ▼
▼
|
Jim's
rating on
this stock |
STOCK
SYMBOL |
Closing
price that
day |
Full Company Name |
|
 |
FNFG |
12.17 |
|
'Mad
Mail'
First Niagara Financial Group
Inc. (FNFG)
Q:
Jim,
You have been recommending some
of the regional bank stocks
including First Niagara. I
recall you stating in the past
that it is important to invest
in sectors that are favored by
the institutional investors.
Almost every opinion voiced by
commentators and advisors seem
to bash regional banks because
of their exposure to commercial
real estate. First Niagara seems
to be slowly going down. What is
it going to take to reverse this
trend?
Don
Jim:
Don,
there will be many failed banks
coming up, many, many… what is
going to happen… and we are
going to have Sheila Bair on
this show tomorrow, she is our
fave from the FDIC… you are
going to see banks that are well
capitalized like First Niagara
being able to buy other banks
that get in trouble… that is why
I like FNFG, it reminds me very
much of some of the banks like
Fleet that I invested in in the
late ‘80’s.
|
|
|
 |
PFE |
14.25 |
|
'Mad
Mail'
Pfizer (PFE)
Q:
I
started purchasing Pfizer early
this year because of the
acquisition of Wyeth. With the
acquisition it was said that
Pfizer would be able to see some
great profits and returns from
the deal. Now with healthcare
and pharma being on Obama’s hit
list, how could this impact
PFE’s stock and will it? Thank
you for your time and a great
big Army BOOYAH!!
Jerome
Jim:
Hey,
thank you for serving… and let’s
remember Memorial Day… and
remember whey we celebrate… and
to say that I just do not think
that Pfizer has anything going
for it… I do not think the
merger is going to matter… I
think that it is a dead weight
stock, and I do not want you
buying Pfizer.
|
|
[verbatim recap]
[end of segment]
Read Jim's next Segment
here
▼ ▼
▼ ▼
▼
Read Jim's next Segment
here
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
|
|
|
Search for Jim's past comments about a specific
stock. Use
ticker symbol or company name in quotes
(e.g., GOOG or "Google") |
|
 |
|
|
|
|
|
|
